Carmot Therapeutics Secures $500,159 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=89a05aca-f294-4f98-8102-eb4ffb58d62d&Preview=1
Date
7/18/2012
Company Name
Carmot Therapeutics
Mailing Address
409 Illinois Street San Francisco, CA 94158
Company Description
Chemotype Evolution is a patent pending technology that was invented by Drs. Stig K. Hansen and Daniel A. Erlanson while they were working at Sunesis Pharmaceuticals. Carmot Therapeutics was founded by Drs. Hansen and Erlanson in 2008 with the goal of commercializing and further developing the technology.
Website
http://www.carmot.us
Transaction Type
Venture Equity
Transaction Amount
$500,159
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed